State Street’s Nutex Health NUTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.7M Buy
123,177
+36,385
+42% +$4.46M ﹤0.01% 2535
2025
Q4
$14.3M Buy
86,792
+9,052
+12% +$1.2M ﹤0.01% 2438
2025
Q3
$8.03M Buy
77,740
+14,919
+24% +$1.46M ﹤0.01% 2754
2025
Q2
$7.82M Buy
62,821
+48,864
+350% +$6.31M ﹤0.01% 2734
2025
Q1
$656K Buy
13,957
+2,400
+21% +$117K ﹤0.01% 3529
2024
Q4
$366K Buy
11,557
+1,200
+12% +$34.2K ﹤0.01% 3705
2024
Q3
$225K Buy
+10,357
New +$149K ﹤0.01% 3798
2024
Q2
Sell
-559
Closed -$8.05K 4383
2024
Q1
$8.05K Hold
559
﹤0.01% 4336
2023
Q4
$15.1K Sell
559
-1,392
-71% -$43.4K ﹤0.01% 4366
2023
Q3
$59.3K Buy
1,951
+14
+0.7% +$675 ﹤0.01% 4245
2023
Q2
$123K Sell
1,937
-25,506
-93% -$2.19M ﹤0.01% 4170
2023
Q1
$4.16M Buy
27,443
+1,231
+5% +$249K ﹤0.01% 3059
2022
Q4
$7.47M Buy
26,212
+21,173
+420% +$4.07M ﹤0.01% 2860
2022
Q3
$1.13M Buy
5,039
+942
+23% +$400K ﹤0.01% 3571
2022
Q2
$1.98M Buy
+4,097
New +$4.83M ﹤0.01% 3483

Other funds holding NUTX

State Street's NUTX Position: Q1 2026 in Review

State Street increased its Nutex Health (NUTX) stake by 42% in Q1 2026, buying an estimated $4.46M and bringing the position to 123,177 shares worth $11.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2535.

State Street first reported a position in NUTX in Q2 2022 and has held it in 15 quarters since. The position peaked at $14.3M in Q4 2025. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • State Street held 123,177 shares of Nutex Health worth $11.7M as of Q1 2026.
  • State Street bought 36,385 Nutex Health shares in Q1 2026, an estimated $4.46M.
  • Nutex Health made up ﹤0.01% of State Street's portfolio in Q1 2026, its #2535 holding.
  • State Street first reported a position in Nutex Health in Q2 2022 and has held it in 15 quarters since.
  • State Street's Nutex Health position peaked at $14.3M in Q4 2025.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.